Oculis (OCSAW) Competitors $6.66 +0.00 (+0.00%) As of 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock OCSAW vs. ATNFW, SXTPW, DRTSW, APLMW, BCTXW, CDIOW, CELUW, CEROW, CINGW, and CLNNWShould you be buying Oculis stock or one of its competitors? The main competitors of Oculis include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Celularity (CELUW), CERo Therapeutics (CEROW), Cingulate (CINGW), and Clene (CLNNW). These companies are all part of the "biotechnology" industry. Oculis vs. Its Competitors 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Celularity CERo Therapeutics Cingulate Clene 180 Life Sciences (NASDAQ:ATNFW) and Oculis (NASDAQ:OCSAW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation. Is ATNFW or OCSAW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Oculis N/A N/A N/A Which has stronger earnings & valuation, ATNFW or OCSAW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AOculisN/AN/AN/AN/AN/A Does the media prefer ATNFW or OCSAW? In the previous week, 180 Life Sciences had 1 more articles in the media than Oculis. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Oculis. 180 Life Sciences' average media sentiment score of 1.14 beat Oculis' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive Oculis Neutral Summary180 Life Sciences beats Oculis on 2 of the 2 factors compared between the two stocks. Get Oculis News Delivered to You Automatically Sign up to receive the latest news and ratings for OCSAW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OCSAW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OCSAW vs. The Competition Export to ExcelMetricOculisBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$138.92M$5.73B$9.56BDividend YieldN/A3.74%4.53%4.08%P/E RatioN/A3.8930.4625.16Price / SalesN/A4,037.10392.5787.62Price / CashN/A13.1937.0358.50Price / BookN/A46.948.956.21Net IncomeN/A-$90.99M$3.26B$265.38M7 Day Performance-0.66%1.90%1.06%-1.13%1 Month Performance-9.29%5.38%4.31%-0.71%1 Year Performance244.00%193.14%28.39%18.86% Oculis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OCSAWOculisN/A$6.88+3.3%N/A+233.0%$0.00N/A0.0032Gap UpATNFW180 Life SciencesN/A$0.39-29.1%N/A+3,378.3%$0.00N/A0.007Positive NewsGap UpHigh Trading VolumeSXTPW60 Degrees PharmaceuticalsN/A$0.09-10.5%N/AN/A$0.00$665.45K0.002Positive NewsDRTSWAlpha Tau MedicalN/A$0.30+13.8%N/A+52.1%$0.00N/A0.0080Positive NewsGap UpAPLMWApollomicsN/A$0.03+17.6%N/A+121.0%$0.00N/A0.0059Positive NewsShort Interest ↓Gap DownBCTXWBriaCell TherapeuticsN/A$0.03-1.4%N/A-89.0%$0.00N/A0.008Positive NewsGap DownCDIOWCardio DiagnosticsN/A$0.01-0.7%N/A-70.5%$0.00$19.90K0.007Positive NewsShort Interest ↓Gap DownCELUWCelularityN/A$0.05+9.9%N/A+109.5%$0.00$54.22M0.00220Positive NewsCEROWCERo TherapeuticsN/A$0.02-7.8%N/A-48.0%$0.00N/A0.008Positive NewsGap DownCINGWCingulateN/A$0.07-6.3%N/A-54.6%$0.00N/A0.0020Positive NewsGap DownCLNNWCleneN/A$0.03+0.4%N/A-1.9%$0.00$350K0.00100Positive NewsGap Up Related Companies and Tools Related Companies ATNFW Alternatives SXTPW Alternatives DRTSW Alternatives APLMW Alternatives BCTXW Alternatives CDIOW Alternatives CELUW Alternatives CEROW Alternatives CINGW Alternatives CLNNW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OCSAW) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access